Admissions to this program begin Fall 2023.
Northeastern University’s Master of Science in Cell and Gene Therapies is a professional master's program, an innovative, nonthesis graduate degree. It combines advanced interdisciplinary training in advanced therapies, such as cell therapies and gene therapies, with the development of high-value business skills critical to success in today’s dynamic workplace. This program is designed to prepare graduates to innovate, collaborate, and lead as research, managerial, or technical professionals in a wide range of the cell and gene therapies fields.
Complete all courses and requirements listed below unless otherwise indicated.
| Code | Title | Hours |
|---|---|---|
| Required Core | ||
| BINF 6200 | Bioinformatics Programming | 4 |
| BIOL 5543 | Stem Cells and Regeneration | 4 |
| BIOL 5583 | Immunology | 4 |
| BIOL 6381 | Ethics in Biological Research | 2 |
| BIOT 5631 | Cell Culture Processes for Biopharmaceutical Production | 3 |
| BIOT 5800 | Gene Therapies | 2 |
| BIOT 5820 | Cellular Therapies | 2 |
| BIOT 5830 | Regulatory Landscape of Cell and Gene Therapies | 2 |
| BIOT 5840 | Cell and Gene Therapy Lab | 3 |
| PMST 6254 | Advanced Drug Delivery Systems | 3 |
| Elective | ||
| Complete a minimum of 3 semester hours from the following to meet the 32 total hours for the program: | 3 | |
| Bioinformatics Computational Methods 1 | ||
| Principles and Applications of Tissue Engineering | ||
| Principles of Bioengineering | ||
| Biological Electron Microscopy | ||
| Stem Cells and Regeneration | ||
| Inventions in Microbial Biotechnology | ||
| Advanced Microbiology | ||
| Medical Microbiology | ||
| Biological Imaging | ||
| Immunology | ||
| Comparative Neurobiology | ||
| Advanced Genomics | ||
| Ethics in Biological Research | ||
| The Role of Patents in the Biotechnology Industry, Past and Future | ||
| Managing and Leading a Biotechnology Company | ||
| Biotechnology Entrepreneurship | ||
| Launching Your Science: Biotechnology Entrepreneurship | ||
| Drug Safety and Immunogenicity | ||
| Introduction to Biotherapeutic Approvals | ||
| Scientific Information Management for Biotechnology Managers | ||
| Concepts in Regulatory Science | ||
| Bioprocess Fundamentals | ||
| Downstream Processes for Biopharmaceutical Production | ||
| Drug Product Processes for Biopharmaceuticals | ||
| Molecular Interactions of Proteins in Biopharmaceutical Formulations | ||
| Cutting-Edge Applications in Molecular Biotechnology | ||
| Higher-Order Structure Analytics | ||
| Pharmaceutical Microbiology | ||
| CGMP Statutes and Regulation | ||
| Quality Management Systems and Validation | ||
| Plant Design and Facilities | ||
| Sterile Manufacturing Operations | ||
| Fundamentals of Chemical Engineering Analysis | ||
| Drug Delivery: Engineering Analysis | ||
| Design of Experiments and Ethical Research (DOEER) | ||
| Biochemical Engineering | ||
| Biomaterials Principles and Applications | ||
| Advanced Topics in Biomaterials | ||
| Co-op | ||
| Professional Development for Co-op | ||
Program Credit/GPA Requirements
32 semester hours required
Minimum 3.000 GPA required